Targeting sigma-1 receptor signaling by endogenous ligands for cardioprotection

Md Shenuarin Bhuiyan, Kohji Fukunaga

研究成果: Review article査読

41 被引用数 (Scopus)


Introduction: The sigma receptors, initially described as a subtype of opioid receptors, are now considered to be a unique receptor expressed in neonatal rat cardiomyocytes and in the plasma membrane of adult rat cardiomyocytes. A number of sigma receptor ligands influence cardiovascular function and the heart has binding sites for sigma receptor ligands that alter contractility both in vivo and in vitro. The human sigma-1 receptor gene contains a steroid-binding component and gonadal steroid dehydroepiandrosterone (DHEA) which interacts with the sigma-1 receptor. Areas covered: We recently documented that the pathophysiological role of the sigma-1 receptor in the heart and its modulation using DHEA, was cardioprotective. Moreover, agonist-induced activation of the sigma-1 receptor modulates diverse ion channels and thereby regulates heart function. Novel concepts for understanding the pathophysiological relevance of sigma-1 receptors in the progression of heart failure, and developing clinical therapeutics targeting for the receptor in cardiovascular diseases are discussed. Expert opinion: Future studies should attempt to develop cardiac-specific knockdown of the sigma-1 receptor to observe its downstream signaling. We expect that these observations will lead to a novel therapeutic target for which a new class of antihypertrophic drugs can be designed.

ジャーナルExpert Opinion on Therapeutic Targets
出版ステータスPublished - 2011 2月

ASJC Scopus subject areas

  • 分子医療
  • 薬理学
  • 創薬
  • 臨床生化学


「Targeting sigma-1 receptor signaling by endogenous ligands for cardioprotection」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。